Pathophysiology of vascular dysfunction in a rat model of chronic joint inflammation

Journal of Physiology

Volumn 557, Issue 2, 2004, Pages 635-643

  Egan, Colin G ^a   Lockhart, John C ^a   Ferrell, William R ^b  

^a UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 [5 (4 CHLOROPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOL 1 YL]BENZENESULFONAMIDE; ACETYLCHOLINE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NITRATE; NITRITE; NITROPRUSSIDE SODIUM; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTANOID; ADJUVANT; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; BODY WEIGHT DISORDER; CHRONIC ARTHRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; ENZYME INHIBITION; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; URINARY EXCRETION; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; ARTHRITIS; BLOOD VESSEL FUNCTION; DRUG EFFECT; JOINT SWELLING; KNEE; KNEE JOINT DIAMETER; MUSCULOSKELETAL SYSTEM PARAMETERS; PROSTAGLANDIN RELEASE; RAT MODEL; URINE LEVEL; VASCULAR ENDOTHELIUM;

ACETYLCHOLINE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BODY WEIGHT; CHRONIC DISEASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; INDOMETHACIN; ISOENZYMES; KNEE JOINT; LASER-DOPPLER FLOWMETRY; MALE; MEMBRANE PROTEINS; NITRATES; NITRIC OXIDE; NITRITES; NITROPRUSSIDE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PYRAZOLES; RATS; RATS, WISTAR; SULFONAMIDES; VASCULAR RESISTANCE;

EID: 3042637509     PISSN: 00223751     EISSN: None     Source Type: Journal    
DOI: 10.1113/jphysiol.2004.062984     Document Type: Article

References (40)

1. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC & Gregory SA (1996). Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 97, 2672-2679.
2. Bileviciute I, Lundeberg T, Ekblom A & Theodorsson E (1993). Bilateral changes of substance P-, neurokinin A- and neuropeptides Y-like immunoreactivity in rat knee joint synovial fluid during acute monoarthritis. Neurosci Lett 153, 37-40.
3. Carpenter MA, Everett LD & Hall MA (1994). High-resolution magnetic resonance imaging of arthritic pathology in the rat knee. Skeletal Radiol 23, 429-437.
4. Dela Torre A, Schroeder RA & Kuo PC (1997). Alteration of NF-kappa B P50 binding kinetics by S-nitrosylation. Biochem Biophys Res Commun 238, 703-706.
5. Egan CG, Lockhart JC, Ferrell WR, Day SM & McLean JS (2002). Pathophysiological basis of acute inflammatory hyperaemia in the rat knee: roles of cyclo-oxygenase-1 and -2. J Physiol 539, 579-587.
6. Egan CG, Lockhart JC, McLean JS & Ferrell WR (2001). Expression of constitutive but not inducible cyclooxygenase maintains articular perfusion in the rat knee. Exp Physiol 86, 191-197.
7. Falchuck KH, Goetzl E & Kulka JP (1970). Respiratory gases of synovial fluid. Am J Med 49, 223-231.
8. Ferrell WR, Lockhart JC, Kelso EB, Dunning L, Plevin R, Meek SE et al. (2003). Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest 111, 35-41.
9. Gierse JK, McDonald JJ, Hauser SD, Rangwala SH, Koboldt CM & Seibert K (1996). A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem 271, 15810-15814.
10. Grabowski PS, England AJ, Dykhuizen R, Copland M, Benjamin N, Reid DM & Ralston SH (1996). Elevated nitric oxide production in rheumatoid arthritis. Detection using the fasting urinary nitrate: creatinine ratio. Arthritis Rheum 39, 643-647.
11. Griffiths RJ (1992). Characterisation and pharmacological sensitivity of antigen arthritis induced by methylated bovine serum albumin in the rat. Agents Actions 35, 88-95.
12. Jang D & Murrell GA (1998). Nitric oxide in arthritis. Free Radic Biol Med 24, 1511-1519.
13. Kang RY, Freire-Moar J, Sigal E & Chu C-Q (1996). Expression of cyclooxygenase-2 in human and an animal model of rheumatoid arthritis. Br J Rheumatol 35, 711-718.
14. Kennedy TA, Smith CJ & Marnett LJ (1994). Investigations of the roles of cysteines in catalysis by prostaglandin endoperoxide synthase. J Biol Chem 269, 27357-27364.
15. Kidd BL, Mapp PI, Gibson SJ, Polak JM, O'Higgins F, Buckland-Wright JC & Blake DR (1989). A neurogenic mechanism for symmetrical arthritis. Lancet 2, 1128-1130.
16. Klareskog L (1989). What can we learn about arthritis from animal models? Springer Semin Immunopathol 11, 315-333.
17. Laine L, Harper S, Simon T, Bath R, Johanson J, Schwartz H et al. (1999). A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group. Gastroenterol 117, 776-783.
18. Lam FY & Ferrell WR (1993). Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience 52, 443-449.
19. Lockhart JC, McMurdo L & Ferrell WR (1997). Vascular reactivity to acetylcholine is attenuated in the inflamed rabbit synovium. J Physiol 501.P, 106P.
20. McDougall JJ (2001). Abrogation of α-adrenergic vasoactivity in chronically inflamed rat knee joints. Am J Physiol Regul Integr Comp Physiol 281, R821-R827.
21. McDougall JJ, Elenko RD & Bray RC (1998). Cholinergic vasoregulation in normal and adjuvant monoarthritic rat knee joints. J Auton Nerv Syst 72, 55-60.
22. McDougall JJ, Karimian SM & Ferrell WR (1995). Prolonged alteration of vasoconstrictor and vasodilator responses in rat knee joints by adjuvant monoarthritis. Exp Physiol 80, 349-357.
23. Mapp PI, Terenghi G, Walsh DA, Chen ST, Cruwys SC, Garrett N et al. (1993). Monoarthritis in the knee induces bilateral and time-dependent changes in substance P and calcitonin gene-related peptide immunoreactivity in the spinal cord. Neurosci 57, 1091-1096.
24. Miranda KM, Espey MG & Wink DA (2001). A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5, 62-71.
25. Mitchell JA, Larkin S & Williams TJ (1995). Cyclooxygenase-2: regulation and pharmacology. Pharmacol Rev 43, 109-142.
26. Moncada S, Palmer RM & Higgs EA (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43, 109-142.
27. Naciazek-Wieniawska A & Krus S (1975). Studies on the cumulation of the toxic effect of indomethacin. Pol Med Sci Hist Bull 15, 35-39.
28. Najafipour H & Ferrell WR (1993). Sympathetic innervation and α-adrenoceptor profile of blood vessels in the posterior region of the rabbit knee joint. Br J Pharmacol 108, 79-84.
29. 2 and sympathetic vasoconstrictor responses in normal and acutely inflamed rabbit knee joints. Exp Physiol 80, 209-220.
30. Richman AI, Su EY & Ho G Jr (1981). Reciprocal relationship of synovial fluid volume and oxygen tension. Arthritis Rheum 24, 701-705.
31. Roth SH (1996). NSAID gastropathy. A new understanding. Arch Intern Med 156, 1623-1628.
32. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG & Needleman P (1993). Nitric oxide activates cyclooxygenase enzymes. Proc Nat Acad Sci U S A 90, 7240-7244.
33. Siegle I, Klein T, Backman JT, Saal JG, Nüsing RM & Fritz P (1998). Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 41, 122-129.
34. Stadler J, Stefanovic-Racic M, Billiar TR, Curran RD, McIntyre LA, Georgescu HI et al. (1991). Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide. J Immunol 147, 3915-3920.
35. Stichtenoth DO & Frölich JC (1998). Nitric oxide and inflammatory diseases. Br J Pharmacol 37, 246-257.
36. Swierkosz TA, Mitchell JA, Warner TD, Botting RM & Vane JR (1995). Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 114, 1335-1342.
37. Verschure PJ, Van Noorden CFJ & Dijkstra CD (1989). Macrophages and dendritic cells during the early phase of antigen-induced arthritis in rats. Immunochemical analysis of cryostat sections of whole rat knee joint. Scand J Immunol 29, 371-381.
38. Wallace JL, Chapman K & McKnight W (1999). Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation. Br J Pharmacol 126, 1200-1204.
39. Wallis JM, Simkin PA & Nelp WB (1985). Low synovial clearance of iodine provides evidence of hypoperfusion in chronic rheumatoid synovitis. Arthritis Rheum 28, 1096-1104.
40. Wood L & Ferrell WR (1984). Response of slowly adapting articular mechanoreceptors in the cat knee joint to alterations in intra-articular volume. Ann Rheum Dis 43, 327-332.